美國據稱將批准為長者和高風險人群注射輝瑞新冠疫苗加強劑量

【彭博】-- 據知情人士，美國食品藥品管理局(FDA)計畫緊急授權第三劑輝瑞-BioNTechx新冠疫苗。

Most Read from Bloomberg

• Istanbul Turns Taps on Old Fountains, Joining Global Push for Free Drinks

• In Paris, the Wrapped Arc de Triomphe Is a Polarizing Package

• How the Child Care Crisis Became a Global Economic Fiasco

• The Global Housing Market Is Broken, and It’s Dividing Entire Countries

• Berlin Referendum Could Determine the Future of the City’s Housing

他們說，針對這一加強劑量預期中的緊急批准，將適用於65歲及以上人群，最易患嚴重疾病的人，以及工作使他們面臨風險的人。計畫周三公佈決定，他們說。

FDA發言人不予評論。輝瑞的代表沒有立即回應彭博尋求評論的請求。

原文標題FDA to Clear Third Pfizer Dose for Older, At-Risk Americans (2)

Most Read from Bloomberg Businessweek

• Evergrande Debt Crisis Is Financial Stress Test No One Wanted

• A Tiny Piece of Plastic Is Helping Farmers Use Far Less Water

• Microsoft and an Army of Tiny Telecoms Are Part of a Plan to Wire Rural America

• In Amazon’s Flagship Fulfillment Center, the Machines Run the Show

• The Energy Future Needs Cleaner Batteries

©2021 Bloomberg L.P.